Barbara Leinweber
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Barbara Leinweber has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- André Scherag
Institute of Medical Statistics, Computer and Data Sciences, Jena University Hospital, Jena, Germany
1 shared publication - Anna Członkowska
2nd Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
1 shared publication Christoph J.G. Lang
Department of Neurology, Friedrich‐Alexander‐University Erlangen‐Nürnberg, Germany
1 shared publication- Christoph Schrader
Department of Neurology, Hannover Medical School, Hannover, Germany
1 shared publication Harald Hefter
Department of Neurology, Heinrich‐Heine‐University Düsseldorf, Germany
1 shared publicationHartmut H.J. Schmidt
Department of Gastroenterology and General Surgery, Transplant Hepatology, University of Münster, Germany
1 shared publication
Latest Publications
- 25 January 2008
- Published by Wiley in Movement Disorders
- Vol. 23 (1) , 54-62
Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's disease
Wilson's disease (WD) is an inherited autosomal‐recessive disorder of copper metabolism characterized by a wide variety of neurological, hepatic, and psychiatric symptoms. The aim of the present study was the development and evaluation of a clinical rating scale, termed Unified Wilson's Disease Rating Scale (UWDRS), to assess the whole spectrum of clinical symptoms in WD. Altogether 107 patients (mean age 37.6 ± 11.9 years; 46 male, 61 female) with treated WD participated in the study. Cronbach's alpha as a measure of the internal consistency for the entire scale was 0.92, whereas the intraclass correlation coefficient (ICC) was 0.98 (confidence interval (CI95%) 0.97–0.99), indicating an excellent interrater reliability as determined in 32 patients. Besides the total score was significantly correlated with the earning capacity of the patients as indicated by an estimated Spearman's ρ ≈ 0.54 (CI95% 0.40–0.69, P < 0.001). In summary, the UWDRS appears to be a promising tool to assess the disease severity in WD. Its usefulness in clinical research and drug trials should be further addressed. © 2007 Movement Disorder Society
- 25 January 2008
- Published by Wiley in Movement Disorders
- Vol. 23 (1) , 54-62
Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's disease
Wilson's disease (WD) is an inherited autosomal‐recessive disorder of copper metabolism characterized by a wide variety of neurological, hepatic, and psychiatric symptoms. The aim of the present study was the development and evaluation of a clinical rating scale, termed Unified Wilson's Disease Rating Scale (UWDRS), to assess the whole spectrum of clinical symptoms in WD. Altogether 107 patients (mean age 37.6 ± 11.9 years; 46 male, 61 female) with treated WD participated in the study. Cronbach's alpha as a measure of the internal consistency for the entire scale was 0.92, whereas the intraclass correlation coefficient (ICC) was 0.98 (confidence interval (CI95%) 0.97–0.99), indicating an excellent interrater reliability as determined in 32 patients. Besides the total score was significantly correlated with the earning capacity of the patients as indicated by an estimated Spearman's ρ ≈ 0.54 (CI95% 0.40–0.69, P < 0.001). In summary, the UWDRS appears to be a promising tool to assess the disease severity in WD. Its usefulness in clinical research and drug trials should be further addressed. © 2007 Movement Disorder Society